Inflammatory Myopathies and Dermatomyositis
Inflammatory Myopathies and Dermatomyositis is a research topic within Epidemiology. Science Explorer counts 17k research works in it since 1950. 12.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers covers the epidemiology, classification, and clinical features of inflammatory myopathies such as dermatomyositis and polymyositis. It includes discussions on autoantibodies, interstitial lung disease, cancer risk, treatment strategies, myositis-specific antibodies, juvenile dermatomyositis, and the association with malignancy.
- Inflammatory Myopathies
- Dermatomyositis
- Polymyositis
- Autoantibodies
- Interstitial Lung Disease
- Cancer Risk
- Treatment
- Myositis-specific Antibodies
- Juvenile Dermatomyositis
- Malignancy
- Research works
- 17k fractional, since 1950
- In the world top 10%
- 2.1k per year above
- Top-10% rate
- 12.3% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +44% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Inflammatory Myopathies and Dermatomyositis research?
By volume, the United States and China publish the most (786 and 419 works in 2022–2025).
By volume, 2022–2025
- 1 United States 786 works
- 2 China 419 works
- 3 Japan 299 works
- 4 United Kingdom 207 works
- 5 India 192 works
- 6 France 168 works
- 7 Italy 164 works
- 8 Germany 130 works
- 9 Spain 121 works
- 10 Brazil 100 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Inflammatory Myopathies and Dermatomyositis research?
By volume in 2022–2025, Johns Hopkins University publishes the most Inflammatory Myopathies and Dermatomyositis research, followed by China-Japan Friendship Hospital and Johns Hopkins Medicine.
By volume, 2022–2025
- 1 Johns Hopkins UniversityUnited States 21 works
- 2 China-Japan Friendship HospitalChina 16 works
- 3 Johns Hopkins MedicineUnited States 15 works
- 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 15 works
- 5 University of PennsylvaniaUnited States 14 works
- 6 University College LondonUnited Kingdom 13 works
- 7 University of PaduaItaly 13 works
- 8 University of PittsburghUnited States 12 works
- 9 InsermFrance 12 works
- 10 National Center of Neurology and PsychiatryJapan 12 works
Who are the leading researchers in Inflammatory Myopathies and Dermatomyositis?
The most-cited researchers publishing on Inflammatory Myopathies and Dermatomyositis include William J. McKenna.
- 1 William J. McKenna United Kingdom 2.3k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Inflammatory Myopathies and Dermatomyositis research done?
The largest centres of Inflammatory Myopathies and Dermatomyositis research in 2022–2025 are Beijing (China), Tokyo (Japan), Paris (France) and London (United Kingdom). Among places with at least 20 works in it, it is an unusually large share of all research in Tunis.
Largest cities, 2022–2025
Where it is the local speciality
- TunisTN · 22.0 works9.3×
Location quotient: how much more of its research is in Inflammatory Myopathies and Dermatomyositis than the world average.
Where is the best place to study Inflammatory Myopathies and Dermatomyositis?
Among universities, judged by research, Johns Hopkins University, University of Pennsylvania and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Johns Hopkins UniversityUnited States | 62.5 | 23.0% | 5.6× | 21 | +35.8% |
| 2 | University of PennsylvaniaUnited States | 52.2 | 13.6% | 4.4× | 14 | +275.0% |
| 3 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 47.9 | 19.9% | 4.3× | 15 | +54.3% |
| 4 | University of PaduaItaly | 47.6 | 22.2% | 4.8× | 13 | -11.3% |
| 5 | University of MichiganUnited States | 46.3 | 30.4% | 1.9× | 9 | +120.1% |
| 6 | University College LondonUnited Kingdom | 45.8 | 17.7% | 2.8× | 13 | +65.9% |
| 7 | Peking UniversityChina | 44.7 | 17.0% | 2.0× | 11 | +238.3% |
| 8 | University of PittsburghUnited States | 43.7 | 18.2% | 4.7× | 12 | +37.4% |
| 9 | Karolinska InstitutetSweden | 41.2 | 18.2% | 5.3× | 8 | +3.1% |
| 10 | The University of TokyoJapan | 35.9 | 26.7% | 2.1× | 9 | +2.6% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Inflammatory Myopathies and Dermatomyositis research growing?
Output in 2018–2022 was 44% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Inflammatory Myopathies and Dermatomyositis.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.